For the functional study, we found that overexpression of RNF113A significantly inhibited AML cell proliferation, enhanced drug sensitivity, and effectively alleviated the leukemia-promoting effects caused by METTL3 overexpression in vitro (Fig. 4L-M). Here, RNF113A is linked to acute myeloid leukemia.